Literature DB >> 26410241

Safety evaluation of signalized intersections with left-turn waiting area in China.

Xinguo Jiang1, Guopeng Zhang2, Wei Bai2, Wenbo Fan2.   

Abstract

In recent years the metropolitans in China have seen the surging installations of the left-turn waiting area (LWA) at the signalized intersections. The design allows the left-turning vehicles to enter the intersection at the onset of the through green phase (of the same approach) and wait for the exclusive left-turn signal at the LWA. The LWA layout can effectively reduce the probability of stranded and queue overflow of the left-turn vehicles, but no study is conducted yet to assess the safety performance of the signalized intersections with LWA. The paper adopts the traffic conflict technique (represented by post-encroachment time), compares the discrepancy of conflict types between intersections with LWA and without, and develops the severity models to identify the contributing factors for the left-turn conflicts. Results demonstrate that the left-turn volume, driving outside the LWA, running red light, the presence of secondary conflicts, and the rear-end conflicts significantly increase the severities of traffic conflicts at the LWA. The findings serve to provide recommendations to revise the current design standard of the LWA (GB5768-2009) and consequently improve the safety operations of signalized intersections with LWA in China.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  Affic conflict technique; Left-turn waiting area; Ordered probit model; Post-encroachment time

Mesh:

Year:  2015        PMID: 26410241     DOI: 10.1016/j.aap.2015.09.006

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  1 in total

1.  Left-turning vehicle-pedestrian conflicts at signalized intersections with traffic lights: Benefit or harm? A two-stage study.

Authors:  Yi-Ling He; Ruo-Tong Li; Li Li; David C Schwebel; He-Lai Huang; Qing-Yi Yin; Guo-Qing Hu
Journal:  Chin J Traumatol       Date:  2019-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.